<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: detailing</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'detailing'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22detailing%22&t=%22detailing%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:51:24 +0100</lastBuildDate>
        <item>
            <title>Court Extends Commercial Speech Protections</title>
            <link>http://www.medworm.com/index.php?rid=4975845&amp;cid=t_158268_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FH4gEql8vpE8%2F</link>
            <description>By Ilya ShapiroIn an important but little-noted First Amendment case decided Thursday, Sorrell v. IMS Health Inc., the Supreme Court correctly invalidated a particular regulation of commercial speech but unfortunately left intact the general doctrine that distinguishes and privileges noncommercial speech.  Justice Kennedy authored the 6-3 decision (joined not just by the “conservatives” but also Justice Sotomayor) that struck down a Vermont law prohibiting the sale of information about doctors’ prescription histories as making viewpoint-based speech restrictions in violation of the First Amendment. 
In so ruling, the Court effectively affirmed a Second Circuit decision (involving a similar Connecticut law) I discussed previously.  Cato filed amicus briefs in both the Second Circui...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4975845</comments>
            <pubDate>Mon, 27 Jun 2011 13:01:36 +0100</pubDate>
            <guid isPermaLink="false">4975845</guid>        </item>
        <item>
            <title>Academic Physicians Promulgate &quot;Principles of Conservative Prescribing&quot; to Limit Patient Exposure to Drug Risks</title>
            <link>http://www.medworm.com/index.php?rid=4945191&amp;cid=t_158268_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2011%2F06%2Facademic-physicians-promulgate.html</link>
            <description>A shift toward more conservative medication-prescribing practices would serve patients better and counterbalance prescribing pressures from the drug industry, according to a review article published Online First today by Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal’s Less Is More series.The authors argue that physicians -- especially young physicians, &quot;who lack historical knowledge of past drug harms and withdrawals from the market&quot; -- should resist the urge to prescribe the &quot;latest and greatest&quot; drugs, a tendency, say the authors, that is &quot;congruent with the messages and interests of the pharmaceutical industry.&quot;The proposed &quot;Principles of Conservative Prescribing&quot; address practically every tactic the pharmaceutical industry uses t...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4945191</comments>
            <pubDate>Mon, 13 Jun 2011 20:59:00 +0100</pubDate>
            <guid isPermaLink="false">4945191</guid>        </item>
        <item>
            <title>What Doctors Do With Their Smartphones</title>
            <link>http://www.medworm.com/index.php?rid=4664480&amp;cid=t_158268_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FikaN3cDXxU8%2F</link>
            <description>Control yourselves. This is all business. A new survey of nearly than 5,500 docs finds that ownership, not surprisingly, is up, with 67 percent of specialists and 61 percent of primary care physicians now possessing these addictive little appendages. Pediatricians are lagging a bit as only 59 percent admit to ownership, but that represents an 11 percent increase from last year.
And what about tablets? These, too, are gaining ground - 27 percent of both specialists and PCPs have one, although we do not know if they favor the iPad over the Nook or Kindle, for instance. However, this would suggest five times as many docs own a tablet compared with the population at large, according to Knowledge Networks, which conducted the survey (see the statement).
But what are they doing with these device...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4664480</comments>
            <pubDate>Thu, 31 Mar 2011 12:34:20 +0100</pubDate>
            <guid isPermaLink="false">4664480</guid>        </item>
        <item>
            <title>The First Amendment Protects All Speech</title>
            <link>http://www.medworm.com/index.php?rid=4642576&amp;cid=t_158268_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FC313665Ucqo%2F</link>
            <description>By Ilya ShapiroVermont passed a law prohibiting the exchange of a variety of socially important information. Most notably, the law outlaws the transfer of doctors' prescription history to facilitate drug companies' one-on-one marketing — a practice known as &quot;detailing&quot; — because it believes detailing drives up brand-name drug sales and, in turn, health care costs. The state knew that the First Amendment prevented it from banning detailing itself, so it made the practice more difficult indirectly.
Yet data collection and transfer are protected speech — think academic research, or the phone book — and government efforts to regulate this type of speech also runs afoul of the First Amendment. See, e.g., Solveig Singleton, Cato Policy Analysis No. 295, &quot;Privacy as Censorship: A Skeptica...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4642576</comments>
            <pubDate>Mon, 28 Mar 2011 11:50:56 +0100</pubDate>
            <guid isPermaLink="false">4642576</guid>        </item>
        <item>
            <title>Going Online: More Drugs Are Promoted On The Net</title>
            <link>http://www.medworm.com/index.php?rid=4175972&amp;cid=t_158268_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FFvPTSac3G7I%2F</link>
            <description>Drugmakers may be squeamish about social media and their web sites may not be choice destinations for most consumers (see this), but the pharmaceutical industry is not shying away from using the Internet to promote meds to docs. A new analysis shows more than 150 drugs were marketed for the first time using online details and events during the first nine months of 2010, which marks a new record.
Leading the pack was Merck&amp;#8217;s Singulair asthma med, with more than 110,400 different so-called e-promotional activities that cost more than $15.5 million to generate, a 2.9 percent increase. The runner-up was Pfizer&amp;#8217;s Pristiq, which is sold to treat depression - e-promotions rose nearly 74 percent to more than 103,700 activities that cost $13.6 million, an 86 percent rise. (In case you w...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4175972</comments>
            <pubDate>Wed, 17 Nov 2010 15:08:16 +0100</pubDate>
            <guid isPermaLink="false">4175972</guid>        </item>
        <item>
            <title>Minnesota Legislature Debates Pharma Influence</title>
            <link>http://www.medworm.com/index.php?rid=3205114&amp;cid=t_158268_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F77NYriYG8sU%2F</link>
            <description>An unusual joint hearing of two committees in the Minnesota legislature - the Commerce and Labor and the Business, Industry and Jobs committees - will take place today to debate three bills designed to improve doctors&amp;#8217; prescribing skills, reduce the influence of pharmaceutical companies and perhaps reduce overall drug spending by consumers.
The undertaking pits a recently formed advocacy group, the Minnesota Prescription Coalition, which favors evidence-based prescribing, fewer conflicts of interest issues in medical field, and reduced spending on prescription drugs, against an array of drugmakers and doctors, including some from the Association of Clinical Researchers and Educators, who claim their relationship with industry results in better patient care.
The proposed bills would s...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3205114</comments>
            <pubDate>Mon, 25 Jan 2010 13:31:31 +0100</pubDate>
            <guid isPermaLink="false">3205114</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=3194019&amp;cid=t_158268_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FFMjUpfVai_k%2F</link>
            <description>Hello, everyone. How are you? The Pharmalot corporate campus is humming as we prepare various short people for the trip to this or that schoolhouse - always an adventure. Meanwhile, there is much to do, as you know all too well. So time to dig in and attack the meetings and deadlines. Here are a few items to help you along. Have a good day&amp;#8230;
Merck HIV Drug Fails Trial (Reuters)
Judge OKs Plaintiff Experts In HRT Cases (The Legal Intelligencer)
Ipsen Buys A Stake In Inspiration Pharma (Bloomberg News)
Roche&amp;#8217;s Xeloda Keeps Patients Cancer-Free Longer (Reuters)
Merck&amp;#8217;s Diarrhea Drug Lowered Infections (Bloomberg News)
Pfizer Doubles E-Detailing Spending (Medical Marketing &amp;#038; Media) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3194019</comments>
            <pubDate>Thu, 21 Jan 2010 11:43:40 +0100</pubDate>
            <guid isPermaLink="false">3194019</guid>        </item>
        <item>
            <title>Pharma Spending On Detailing Is Up: CBO</title>
            <link>http://www.medworm.com/index.php?rid=3056885&amp;cid=t_158268_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FLdYhC8jK_Cg%2F</link>
            <description>A new report from the Congressional Budget Office examines promotional spending by drugmakers, including an analysis of direct-to-consumer advertising in recent years. For those in the know, there are probably few surprises. Nonetheless, the summary is interesting and worth noting. Here are some highlights&amp;#8230;
- In 2008, spending on DTC ads totaled $4.7 billion, nearly one-fourth of industry spending for all promotional activities. Promotional spending, which includes detailing, ad journals, meetings and DTC ads, was $20.5 billion last year, or 10.8 percent of US sales last year. The CBO, which says spending was typically between 10 percent and 12 percent since the early 1990&amp;#8217;s, cited sales data reported by PhRMA, which presumably relies on annual reports. DTC advertising has decl...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3056885</comments>
            <pubDate>Thu, 03 Dec 2009 18:57:10 +0100</pubDate>
            <guid isPermaLink="false">3056885</guid>        </item>
        <item>
            <title>Sales Managers Gripe About Lousy Training</title>
            <link>http://www.medworm.com/index.php?rid=2894769&amp;cid=t_158268_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FhBqoXg1562g%2F</link>
            <description>The continual shrinking of the pharmaceutical industry&amp;#8217;s sales forces increasing resembles &amp;#8216;The Death of a Salesman&amp;#8217; scenario. But those responsible for overseeing the thousands of remaining reps say that some of the problems can be laid at the doorstep of their own employers - there simply isn&amp;#8217;t enough resources and thought given to helping managers improve their own skills.
At least that&amp;#8217;s what a survey of more than 100 district sales managers, marketing directors and vp&amp;#8217;s from 20 pharma companies, including eight of the largest drug makers, which was conducted by Delta Point, a consulting firm. The upshot: &amp;#8220;A significant gap exists between the importance placed on skills that enhance customer relationships and the training structure and opportun...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2894769</comments>
            <pubDate>Thu, 15 Oct 2009 12:36:47 +0100</pubDate>
            <guid isPermaLink="false">2894769</guid>        </item>
        <item>
            <title>Academic Detailing the New York City Way (Public Health over Rhetoric)</title>
            <link>http://www.medworm.com/index.php?rid=2347739&amp;cid=t_158268_87_f&amp;fid=37069&amp;url=http%3A%2F%2Fpolicymed.com%2F2009%2F04%2Facademic-detailing-the-new-york-city-way-public-health-over-rhetoric.html</link>
            <description>Congress and others have been promoting the value of academic detailing as a way to reduce drug costs by promoting generic drugs.&amp;#0160;&amp;#0160; The New York Department of Public health has a better idea.&amp;#0160; The city has solicited help from pharmaceutical executives to design and execute a public health academic detailing campaign focusing on influenza and pneumococcal vaccine distribution and education, colon and rectal cancer screening and smoking cessation.&amp;#0160; 
In the last 10 months, the city has spent nearly $900,000 on half a dozen detailing campaigns.
Rather than fighting industry to promote older cheaper drugs the New York City Public Health Department has come up with a detailing plan that serves “the public.” 
The proponents of academic detailing should learn from their...</description>
            <author>Policy and Medicine</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2347739</comments>
            <pubDate>Mon, 20 Apr 2009 02:24:31 +0100</pubDate>
            <guid isPermaLink="false">2347739</guid>        </item>
        <item>
            <title>Counter-counter Detailing</title>
            <link>http://www.medworm.com/index.php?rid=1709129&amp;cid=t_158268_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F08%2Fcounter-counter-detailing.html</link>
            <description>The South Carolina Medicaid Academic Detailing Program, aka SCORxE, which stands for South Carolina Offering Prescribing Excellence, was featured in a recent Time Magazine story (see &quot;The States Take On the Drug Pitchmen&quot;).One scenario described in that article got me thinking about the futility of &quot;counter-detailing.&quot;&quot;...a disagreement among the leaders of the state's SCORxE program — designed to educate physicians with unbiased and accurate information about prescription drugs. The basic issue: Should representatives of the program bring the doctors pizza for lunch? Sarah Ball, the indefatigable pharmacist who leads SCORxE, says no. The whole point of SCORxE, after all, is to counteract Big Pharma's hard-sell drug marketing. But sometimes you have to fight fire with fire, says Dr. Robe...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1709129</comments>
            <pubDate>Fri, 15 Aug 2008 12:51:00 +0100</pubDate>
            <guid isPermaLink="false">1709129</guid>        </item>
        <item>
            <title>Academic Detailing Bill Is Introduced In Congress</title>
            <link>http://www.medworm.com/index.php?rid=1671778&amp;cid=t_158268_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F351607267%2F</link>
            <description>In an effort to dilute the impact of sales reps, several Senators and Congressmen today are introducing a bill that would create funding for a program to send trained pharmacists, nurses, and other health care professionals into a doctor&amp;#8217;s office with independent data about benefits, risks, costs, and comparative effectiveness of prescription drugs, including generics.
The Independent Drug Education and Outreach Act of 2008 would make it possible to fund grants or contracts through the HHS Agency for Health Care Research and Quality to develop educational materials and to send trained medical professionals to a doc&amp;#8217;s office to discuss &amp;#8220;unbiased information on appropriate prescribing,&amp;#8221; according to a summary of the bill. (Here is the Senate version.)
Applicants may n...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1671778</comments>
            <pubDate>Thu, 31 Jul 2008 14:48:52 +0100</pubDate>
            <guid isPermaLink="false">1671778</guid>        </item>
        <item>
            <title>Consumers Want Gifts To Docs Disclosed: Survey</title>
            <link>http://www.medworm.com/index.php?rid=1526774&amp;cid=t_158268_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F314727162%2F</link>
            <description>A majority of Americans - 68 percent - support legislation to require drugmakers to disclose gifts and payments to docs, according to a new survey by the Prescription Project. Americans also disapprove of many types of gifts and payments to docs, support legislation that would allow clinical experts to provide unbiased drug info to doc in the form of academic detailing, and think pharma has a moderate to extremely large influence on prescribing patterns by docs.
Other findings: 52 percent say accepting gifts from pharma influences how docs make prescribing decisions and another 26 percent believe gifts have a moderate influence. 86 percent believe free dinners should not be allowed; 80 percent believe speaking fees shouldn&amp;#8217;t allowed; 78 percent believe free lunches at the office shou...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1526774</comments>
            <pubDate>Wed, 18 Jun 2008 16:08:25 +0100</pubDate>
            <guid isPermaLink="false">1526774</guid>        </item>
        <item>
            <title>Senate Bill To Create Federal Academic Detailing</title>
            <link>http://www.medworm.com/index.php?rid=1292355&amp;cid=t_158268_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F249122457%2F</link>
            <description>You&amp;#8217;ve heard about the program in Pennsylvania, for instance? The state funds a group of so-called academic detailers who, essentially, try to counter industry sales reps by providing nothing but straight talk and informative handouts created by a team of doctors. Now, the Senate Special Committee on Aging will hold a hearing on Wednesday to consider a federal academic detailing program.
&amp;#8220;The industry’s educational outreach is essentially a marketing program, and evidence shows that doctors’ prescribing patterns can be heavily influenced by pharmaceutical sales representatives,&amp;#8221; according to a statment issued this afternoon by the committee. &amp;#8220;The hearing will consider the implications of creating a &amp;#8216;federal academic detailing&amp;#8217; program, which would pr...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1292355</comments>
            <pubDate>Mon, 10 Mar 2008 21:57:48 +0100</pubDate>
            <guid isPermaLink="false">1292355</guid>        </item>
        <item>
            <title>Counter Detailing -- Pissing into the Wind or Profitable Endeavor?</title>
            <link>http://www.medworm.com/index.php?rid=1061040&amp;cid=t_158268_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F11%2Fcounter-detailing-pissing-into-wind-or.html</link>
            <description>Pissing into the Wind: Engaging in a pointless activity.That's how I see Dr. Dan Carlat's new focus on redeeming himself by engaging in some freelance &quot;counter detailing&quot; in his home state of Massachusetts.You'll recall that Carlat recently wrote a true confession of how he earned $30,000 as an MD shill for Wyeth a few years ago (see &quot;Dr. Carlat's True Confession: 199,999 More to Go&quot;).Many people called for him to give the $30,000 to charity or back to Wyeth, but Carlat demured.Carlat explained on his blog and in an interview with Ed Silverman over at Pharmalot that &quot;I'll be doing the opposite of what I did with Effexor, which was to give drug talks. Instead, I’ll be visiting different doctors, different practitioners in different places in the area and try to educate them about direct-t...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1061040</comments>
            <pubDate>Fri, 30 Nov 2007 12:02:00 +0100</pubDate>
            <guid isPermaLink="false">1061040</guid>        </item>
    </channel>
</rss>

